Corleone S. Delaveris
University of California, San Francisco
ORCID: 0000-0002-7291-2338Also affiliated with Rapt Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19”.
Aaron J. Wilk, Nicholas M. Riley, Jessica C. Stark, Samuel Yang, Angela J. Rogers +5 more
Aaron J. Wilk, Nicholas M. Riley, Jessica C. Stark, Samuel Yang, Angela J. Rogers +5 more
S. Y. Chiu, Nicholas M. Riley, Carolyn R. Bertozzi, Corleone S. Delaveris
Shannon Chiu, Nicholas M. Riley, Carolyn R. Bertozzi, Corleone S. Delaveris
Shannon H. Chiu, Nicholas M. Riley, Carolyn R. Bertozzi, Corleone S. Delaveris
Catherine L. Wang, Nicholas M. Riley, Sherry Li, Rishikesh U. Kulkarni, Carolyn R. Bertozzi +1 more
Catherine L. Wang, Nicholas M. Riley, Sherry Li, Rishikesh U. Kulkarni, Carolyn R. Bertozzi +1 more
Sophie Kong, Jeff E. Glasgow, Rita P. Loudermilk, Lisa L. Kirkemo, Fangzhu Zhao +6 more
Sophie Kong, Jeff E. Glasgow, Rita P. Loudermilk, Lisa L. Kirkemo, Fangzhu Zhao +6 more